innerbuddies gut microbiome testing

Gut Microbiome and Neuroinflammation: How Your Microbiota Affects Brain Health

Your gut and brain are in constant communication—through the nervous system, immune signaling, microbial metabolites, and the integrity of the gut barrier. When the gut microbiome is balanced, it can help regulate inflammation and support brain function. But when microbial diversity drops or harmful strains expand, the immune system may become overactive, setting the stage for neuroinflammation.

Neuroinflammation isn’t just “brain inflammation”—it’s often influenced by what’s happening in the gut. Microbes and the compounds they produce (like short-chain fatty acids, bile acid metabolites, and neurotransmitter-related metabolites) can shift inflammatory pathways, including cytokine release and immune cell activation. At the same time, dysbiosis may increase gut permeability (“leaky gut”), allowing inflammatory signals and microbial byproducts to travel through the bloodstream and amplify inflammatory activity in the brain.

The good news: microbiota-friendly habits can help steer your gut ecosystem toward a more anti-inflammatory profile. By focusing on fiber-rich, diverse plant foods, supporting healthy fats and protein balance, and reducing gut-disrupting factors (like excess ultra-processed foods and chronic stress), you can promote beneficial microbes that calm inflammation and support brain health. In this guide, we’ll explore the gut-brain connection, key mechanisms, and practical, evidence-informed strategies to help protect your nervous system through your microbiome.

Order Your Gut Microbiome Test Subscribe to Get Your Gut Microbiome Test Kit
innerbuddies gut microbiome testing

Neuroinflammatory interest areas

The gut microbiome communicates with the brain through the gut–brain axis, shaping immune tone, metabolism, and neural function, with neuroinflammation arising when dysbiosis shifts toward pro-inflammatory signaling. Key mechanisms include weakened gut barrier from reduced butyrate-producing bacteria, increased permeability, and systemic inflammatory cascades that can drive neuroimmune activity and glial activation. Microbial metabolites such as short-chain fatty acids, bile acids, and tryptophan–kynurenine pathway products, along with signals like lipopolysaccharide and vagal pathways, connect gut changes to brain inflammation. Diet and lifestyle—especially high-fiber, plant-forward patterns, fermented foods, adequate sleep, physical activity, and stress management—can cultivate beneficial microbes and anti-inflammatory pathways that support barrier integrity and immune balance.

Microbiome testing can reveal dysbiosis and reduced fermentation capacity, guiding targeted strategies to strengthen barrier function and modulate immune signaling. The InnerBuddies test offers context on microbial composition and function, enabling baseline and follow-up tracking to tailor interventions for neuroinflammatory symptoms such as brain fog, mood changes, fatigue, sleep disruption, headaches, and related GI symptoms. Given substantial overlap with functional GI disorders, migraine, anxiety, and sleep disturbances, this area is a broad, clinically relevant target for personalized care.

  • Butyrate-producing bacteria depletion weakens gut barrier and increases intestinal permeability, allowing microbial components to reach immune sites and promote systemic inflammatory signals that can prime neuroinflammation. Key depleted taxa include Faecalibacterium prausnitzii, Roseburia spp., Eubacterium rectale, Anaerostipes spp., and Butyrivibrio spp.
  • Expansion of endotoxin-producing and pro-inflammatory bacteria elevates LPS exposure and systemic cytokine cascades that can influence brain immune activity. Elevated taxa commonly observed include Enterobacteriaceae (Escherichia coli, Klebsiella), Desulfovibrio spp., Bilophila wadsworthia, Parabacteroides spp., Bacteroides fragilis group, and Streptococcus spp.
  • Dysbiosis disrupts microbial metabolite signaling (including bile acid transformations and other non-SCFA metabolites), altering immune regulation and pathways that affect brain inflammation.
  • Microbial metabolism can shift the tryptophan–kynurenine pathway, producing immune-linked metabolites that influence mood, cognition, and neuroinflammation.
  • Gut–brain immune signaling via the vagus nerve and systemic cytokines is shaped by microbiome activity; SCFA producers promote anti-inflammatory signaling along this axis.
  • Akkermansia muciniphila and other barrier-supporting taxa help maintain mucin layer and tight junction integrity; reduced Akkermansia can worsen barrier dysfunction and pro-inflammatory signaling related to neuroinflammation.
Order Your Gut Microbiome Test Subscribe to Get Your Gut Microbiome Test Kit
innerbuddies gut microbiome testing

Cognitive / neurological topics

The gut microbiome—made up of trillions of microbes living primarily in the intestines—actively communicates with the brain through the gut–brain axis, influencing immune tone, metabolic signaling, and neural function. In the context of neuroinflammation, certain microbiome profiles and their metabolic outputs may either promote a pro-inflammatory state or help maintain immune balance. Because intestinal immune cells, gut barrier integrity, and microbial metabolites (such as short-chain fatty acids) can affect systemic inflammation, shifts in microbiota composition are increasingly studied as modifiable contributors to brain health.

Neuroinflammation can be driven or amplified by several microbiota-related pathways, including changes in gut barrier permeability (“leaky gut”), altered microbial signaling to the immune system, and production of metabolites that influence inflammation. For example, reduced short-chain fatty acid–producing bacteria (notably butyrate producers) may weaken barrier function and lower anti-inflammatory signaling. Conversely, certain microbes and bacterial products (e.g., lipopolysaccharide in susceptible contexts) can increase immune activation and promote inflammatory cascades. These immune effects can propagate through systemic cytokines, immune cell trafficking, and signaling routes that ultimately influence neuroimmune activity (including glial activation) and the brain’s inflammatory environment.

Practical microbiota-friendly strategies—especially diet—can support brain health by helping steer inflammation-relevant microbial communities toward beneficial functions. High-fiber, plant-rich eating patterns supply substrates for beneficial fermenters that produce anti-inflammatory metabolites, while fermented foods may provide supportive microbial diversity for some individuals. Lifestyle factors such as adequate sleep, regular physical activity, and stress management also modulate both microbiome composition and immune responses. For people with neuroinflammatory interest areas, the goal is often to encourage a resilient gut ecosystem that improves barrier integrity, reduces inflammatory signaling, and supports regulatory immune pathways—potentially complementing broader neuroinflammation-focused care.

  • Brain fog and difficulty concentrating
  • Mood changes (irritability, anxiety, or depressive symptoms)
  • Chronic fatigue and low energy
  • Headaches or migraine frequency/intensity changes
  • Sleep disturbances (insomnia or non-restorative sleep)
  • Gastrointestinal issues (bloating, diarrhea, constipation) often accompanying neurological symptoms
  • Increased sensitivity to stress and “crash” after meals or poor sleep
Order Your Gut Microbiome Test Subscribe to Get Your Gut Microbiome Test Kit
innerbuddies gut microbiome testing

Neuroinflammatory interest areas

This topic is relevant for people interested in neuroinflammation who suspect a gut contribution to their symptoms—especially when brain fog, poor concentration, mood changes, chronic fatigue, or sleep problems seem to fluctuate alongside diet quality or gut symptoms (like bloating, diarrhea, or constipation). Because the gut–brain axis links intestinal microbes to immune tone and neural function, it can be particularly relevant for those who notice patterns such as feeling worse after high-sugar/low-fiber meals, experiencing “crashes,” or having symptoms intensify during periods of stress, poor sleep, or dietary disruption.

It’s also relevant for individuals exploring microbiome-informed, modifiable strategies to support barrier integrity and reduce inflammatory signaling. If you’re looking to understand how shifts in microbial communities—such as reduced short-chain fatty acid (SCFA)–producing bacteria that help maintain an anti-inflammatory gut environment—may relate to neuroimmune activation (including glial inflammation), this overview is a useful starting point. Those dealing with headaches or migraine changes may also find it relevant, particularly when migraine frequency or intensity tracks with GI disturbances or immune-related triggers.

Finally, this is relevant for anyone wanting to complement broader neuroinflammation-focused care with gut-supportive lifestyle and diet approaches. People who are motivated to try higher-fiber, plant-rich eating patterns, experiment with fermented foods for microbial diversity (as tolerated), and pair these with sleep, stress management, and regular physical activity may benefit from thinking about microbiome pathways. It can be especially useful for individuals who want a practical framework for encouraging a resilient gut ecosystem that supports regulatory immune responses, aiming to improve both neurological symptoms and gastrointestinal discomfort over time.

Neuroinflammation is widespread across many neurologic and psychiatric conditions, but “microbiome-driven neuroinflammatory interest areas” don’t have a single, universally defined prevalence number because they describe a mechanistic pattern rather than one specific diagnosis. Still, major portions of the population experience key neuroinflammation-adjacent symptoms—such as brain fog, mood changes, chronic fatigue, sleep disruption, and headaches—at clinically relevant rates, making microbiome–gut–brain immune signaling a common area of overlap in real-world care.

From an epidemiology standpoint, gut–brain axis involvement is also common. Functional gastrointestinal symptoms (e.g., bloating, constipation, diarrhea, and mixed bowel habits) affect a large share of adults—often estimated in the ~10–20% range globally for irritable bowel syndrome–spectrum presentations, with even higher rates for broader functional GI complaints. Because these GI symptoms frequently co-occur with sleep disturbance, anxiety/depressive symptoms, and cognitive difficulties, a substantial proportion of people may experience gut-immune signaling patterns that can plausibly influence neuroinflammatory tone.

When looking at microbiome-related inflammatory patterns indirectly through comorbidities, the prevalence signals remain high: migraine affects roughly ~10–15% of people worldwide, and anxiety disorders affect about ~1 in 5 adults (~20%) in many epidemiologic surveys. Sleep disorders are similarly prevalent, with insomnia symptoms affecting an estimated ~10–30% of adults depending on definitions and geography. Taken together, the overlap of neuroinflammation-relevant symptoms (brain fog, mood changes, fatigue, headaches, and GI complaints) suggests that microbiome–immune pathways are relevant to a large minority of the population, even though a precise, symptom-matched “prevalence of neuroinflammatory microbiome patterns” is not consistently reported as a standalone condition.

Order Your Gut Microbiome Test Subscribe to Get Your Gut Microbiome Test Kit
innerbuddies gut microbiome testing

Gut Microbiome & Neuroinflammation: How Your Microbiota Affects Brain Health

The gut microbiome and the brain are tightly connected through the gut–brain axis, which links intestinal microbes and their metabolites to immune tone, metabolic signaling, and neural function. In neuroinflammatory interest areas, dysbiosis (an imbalance in microbial communities) may shift the body toward a more inflammatory immune profile by changing how intestinal immune cells communicate with the system. When microbial signaling and immune regulation in the gut are disrupted, it can influence neuroimmune activity, including glial activation and the brain’s inflammatory environment.

One key mechanism is gut barrier integrity. Reduced populations of beneficial, short-chain fatty acid (SCFA)–producing bacteria—especially butyrate producers—can weaken the intestinal lining and promote increased permeability (often described as “leaky gut”). This can allow inflammatory triggers and microbial components to reach immune sites more easily, potentially amplifying systemic cytokine signaling that contributes to neuroinflammation. Conversely, certain microbial products (such as lipopolysaccharide, or LPS, in susceptible contexts) can increase immune activation and help drive inflammatory cascades that may show up as brain fog, mood changes, chronic fatigue, and sleep disruption.

Microbiome-related shifts may also help explain the symptom pattern many people report: gastrointestinal issues (bloating, diarrhea, constipation) alongside cognitive and mood symptoms, headaches or migraine changes, and “crash” feelings after meals or poor sleep. Diet is a major, modifiable lever because high-fiber, plant-forward patterns supply fermentable substrates that support beneficial fermenters and SCFA production, which can reinforce barrier function and support anti-inflammatory pathways. For some individuals, fermented foods may add microbial diversity, while sleep, stress management, and regular activity further shape microbiome composition and immune responses—collectively supporting a more resilient, inflammation-balanced gut ecosystem that may benefit neuroinflammatory outcomes.

Order Your Gut Microbiome Test Subscribe to Get Your Gut Microbiome Test Kit
innerbuddies gut microbiome testing

Gut Microbiome and Neuroinflammatory interest areas

  • Gut barrier dysfunction (“leaky gut”)—reduced SCFA-producing (notably butyrate) bacteria weakens tight junctions, increases intestinal permeability, and allows microbial products to more easily access immune sites
  • Immune tone modulation via gut immune cells—dysbiosis shifts signaling from intestinal immune networks (e.g., altered Treg/Th17 balance) toward a more pro-inflammatory systemic profile that can promote neuroimmune activation
  • Microbial metabolites regulating neuroinflammation—lower SCFA levels (and altered bile acid/other metabolite patterns) reduce anti-inflammatory signaling and can increase inflammatory mediator production affecting the brain
  • Increased exposure to pro-inflammatory microbial components—context-dependent increases in endotoxin (e.g., LPS) and other pathogen-associated molecules enhance systemic cytokines that may drive glial activation and neuroinflammatory cascades
  • Vagus nerve and neural immune crosstalk—microbiome-driven changes in microbial metabolites and signaling molecules can influence vagal afferent activity and downstream brain immune responses
  • Tryptophan–kynurenine pathway effects—microbial shifts can alter tryptophan metabolism and immune-driven kynurenine signaling, which is linked to mood/cognitive changes and inflammatory neurobiology
  • Enteric nervous system and gut inflammation as upstream drivers—gut dysmotility and inflammatory signaling can propagate neuroimmune dysfunction, contributing to headaches/migraine changes, brain fog, and sleep disruption

In neuroinflammatory interest areas, the gut–brain axis provides a practical pathway for how intestinal changes can influence brain immune activity. When the gut microbiome becomes imbalanced (dysbiosis), it can shift the immune “set point” in the gut toward greater inflammatory signaling. This may involve changes in gut immune cell communication (including altered Treg/Th17 balance), which can increase systemic cytokines and prime neuroimmune responses such as glial activation—events that are often associated with brain fog, mood shifts, and fatigue.

A central mechanism is gut barrier dysfunction, sometimes described as “leaky gut.” Beneficial, short-chain fatty acid (SCFA)–producing microbes—especially butyrate producers—help maintain tight junction integrity. When these bacteria decline, SCFA levels drop and the intestinal lining can become more permeable, allowing microbial components and inflammatory triggers to reach immune sites more easily. In susceptible contexts, increased exposure to pro-inflammatory molecules such as endotoxin (LPS) can further amplify immune cascades, increasing inflammatory mediators that can affect neural tissue and contribute to sleep disruption, headaches, or migraine changes.

Microbial metabolites and neural immune crosstalk help connect intestinal events to brain signaling. Altered metabolite production (including reduced SCFAs and changes in bile acid signaling) can weaken anti-inflammatory pathways, while microbiome-driven signals can influence the vagus nerve and downstream brain immune responses. Dysbiosis can also affect the tryptophan–kynurenine pathway, reshaping immune-linked metabolites associated with mood and cognitive symptoms. Meanwhile, gut inflammation and dysmotility from an imbalanced ecosystem can become upstream drivers that propagate neuroimmune dysfunction through the enteric nervous system and immune signaling, reinforcing a cycle that links gastrointestinal symptoms with neuroinflammation.

Order Your Gut Microbiome Test Subscribe to Get Your Gut Microbiome Test Kit
innerbuddies gut microbiome testing

Microbial patterns summary

In neuroinflammatory interest areas, a common microbial pattern is gut dysbiosis characterized by reduced abundance of beneficial, fermentative taxa—particularly short-chain fatty acid (SCFA)–producing bacteria such as butyrate producers. This shift often lowers SCFA output, which can weaken intestinal tight junctions and gut barrier integrity. As permeability increases, microbial-associated molecular patterns and inflammatory triggers are more likely to reach immune sites, promoting a higher baseline inflammatory “set point” that can reverberate along the gut–brain axis.

Alongside lower SCFA-generating communities, many patterns show an altered balance of immune-modulating microbes that can tilt gut immunity toward pro-inflammatory signaling. For some individuals, this manifests as a relative increase in taxa associated with endotoxin (e.g., lipopolysaccharide) exposure and impaired immune tolerance, alongside changes in metabolite signaling that affect downstream neuroimmune activity. Through pathways involving gut cytokine tone, vagal signaling, and systemic immune priming, these microbial patterns may be linked to neuroinflammatory outcomes such as brain fog, mood changes, and fatigue, especially when paired with gastrointestinal symptoms.

Metabolically, neuroinflammatory-associated dysbiosis frequently includes disruptions in microbial metabolite networks beyond SCFAs, including altered bile acid transformations and shifts in tryptophan–kynurenine pathway metabolites that influence immune regulation and brain function. Dysbiosis can also impair motility and promote gut inflammation, creating a feed-forward cycle where inflammatory signals sustain glial activation and contribute to sleep disruption, headache or migraine changes, and post-meal “crash” feelings. Overall, these patterns tend to cluster around reduced fermentation capacity, altered immune signaling metabolites, and compromised gut-immune communication—factors that can help explain the overlap between GI dysfunction and neuroinflammatory symptom domains.


Low beneficial taxa

  • Faecalibacterium prausnitzii (butyrate producer)
  • Roseburia spp. (butyrate producers)
  • Eubacterium rectale (butyrate producer)
  • Anaerostipes spp. (butyrate producers)
  • Butyrivibrio spp. (fiber-fermenting, SCFA-producing)
  • Bifidobacterium spp. (SCFA/acetate producers; immune-modulating)
  • Akkermansia muciniphila (mucin-associated barrier-supporting taxa)


Elevated / overrepresented taxa

  • Enterobacteriaceae (e.g., Escherichia coli, Klebsiella pneumoniae)
  • Bacteroides spp. (notably Bacteroides fragilis group in pro-inflammatory contexts)
  • Ruminococcus gnavus group
  • Bilophila wadsworthia
  • Parabacteroides spp.
  • Desulfovibrio spp. (sulfate-reducing bacteria)
  • Streptococcus spp.


Functional pathways involved

  • Reduced SCFA (butyrate/propionate/acetate) biosynthesis and fermentation capacity
  • Intestinal barrier dysfunction: decreased tight-junction signaling and increased mucin layer stress
  • Microbial pattern translocation and immune priming: lipopolysaccharide (LPS)–driven TLR/NF-κB activation
  • Pro-inflammatory bile acid transformation (e.g., secondary bile acids) and FXR/TGR5 signaling dysregulation
  • Tryptophan–kynurenine pathway shifts affecting aryl hydrocarbon receptor (AhR) and neuroimmune modulation
  • Altered microbial regulation of gut immune tolerance: Treg/Th17 balance and cytokine tone changes
  • Dysbiosis-driven impairment of motility and intestinal inflammation (increased mucus penetration and dysregulated mucosal immunity)
  • Vagal and gut–brain axis signaling modulation via microbial metabolites and cytokines


Diversity note

In neuroinflammatory interest areas, gut microbiome changes often reflect reduced diversity alongside a shift away from microbes that normally support an anti-inflammatory gut environment. A common pattern is lower abundance of SCFA-producing taxa—especially butyrate producers—along with a reduced overall capacity for carbohydrate fermentation. With fewer fermenters, microbial metabolite output such as butyrate typically declines, which can weaken intestinal tight junctions, increase gut permeability, and reduce the gut’s ability to maintain immune tolerance.

At the same time, dysbiosis may also involve a community restructuring in which immune-modulating functions are altered rather than simply “less bacteria.” This can mean a relative enrichment of taxa associated with endotoxin exposure or pro-inflammatory signaling, alongside broader disruptions in metabolite networks that regulate immune tone. Changes in bile acid transformations and in tryptophan-derived metabolite pathways (including shifts toward kynurenine-related immune signaling) can further impair regulation of inflammation and influence downstream neuroimmune activity through gut cytokine signaling and vagal pathways.

When these diversity- and function-related shifts occur together, they can create a feed-forward cycle linking gut dysfunction with neuroinflammatory symptoms. Reduced diversity and fermentation capacity may amplify barrier dysfunction and systemic immune priming, making inflammatory signaling more likely to reach neuroimmune targets such as glial cells. Over time, alterations in microbial metabolites and gut immune communication can coincide with gastrointestinal complaints (bloating, altered stool patterns) and cognitive or mood changes, fatigue, and sleep disruption—reflecting how microbial community changes can reverberate along the gut–brain axis.


Order Your Gut Microbiome Test Subscribe to Get Your Gut Microbiome Test Kit

Why generic solutions fail

  • Issue with generic solutions

    Generic gut–brain or “inflammation” protocols often fail because neuroinflammation is driven by an individual-specific immune–microbiome feedback loop, not a single universal imbalance. In many people, the problem is not simply “more good bacteria” but whether the gut ecosystem has adequate fermentation capacity (e.g., butyrate-producing communities) to maintain barrier integrity and anti-inflammatory signaling. Without addressing the underlying pattern—such as reduced SCFA output, altered immune-tolerance dynamics, or heightened endotoxin-related signaling—generic approaches can improve symptoms transiently while leaving the inflammatory set point intact.

    Another reason broad solutions fall short is that the gut–brain axis is mediated by multiple metabolite pathways and host factors that vary widely. Neuroinflammatory interest areas commonly involve disrupted metabolite networks beyond SCFAs (including bile acid transformation and tryptophan–kynurenine immune signaling metabolites). A one-size-fits-all diet or supplement strategy may not match the person’s dominant bottleneck—motility issues, dysbiosis pattern, sleep/stress-driven immune priming, or specific triggers that increase permeability—so improvements in GI comfort may not translate to cognitive, mood, fatigue, or headache outcomes.

    Finally, “generic” plans often ignore tolerance and timing, which can be critical for inflammatory and neuroimmune states. Fermented foods, high-fiber increases, prebiotic powders, or antimicrobial herbs can help some people but worsen others when the gut barrier is already compromised or when immune signaling is hypersensitive. If interventions are layered without personalization—dose, progression, and trigger assessment—people may experience flares or inconsistent results, reinforcing the misconception that the strategy “doesn’t work,” when the issue is mismatched mechanism and variability in neuroimmune response.

  • Common mistakes

    • Treating neuroinflammation as one universal “gut inflammation” imbalance instead of an individual immune–microbiome feedback loop with a distinct inflammatory set point
    • Assuming more fiber or “more good bacteria” alone fixes the problem, without verifying whether SCFA/butyrate fermentation capacity and gut barrier-supporting communities are actually adequate
    • Using the same prebiotic/fermented/high-fiber or antimicrobial-heavy stack for everyone despite variability in permeability status, motility patterns, and immune hypersensitivity
    • Ignoring endotoxin-related dynamics (e.g., LPS/Gram-negative exposure, impaired immune tolerance) and focusing only on general anti-inflammatory branding or broad symptom suppression
    • Failing to account for key metabolite pathways beyond SCFAs (bile acid transformations and tryptophan–kynurenine immune metabolites) that may be the dominant driver in a given person
    • Layering interventions too fast or without progression/timing, which can trigger flares when the gut barrier is compromised or when vagal/systemic immune priming is already elevated
    • Not addressing gut motility and transit-time issues that can sustain inflammation and dysbiosis, leading to improvements in GI comfort that don’t translate to neuroimmune outcomes
    • Relying on short-term symptom changes (GI “settling”) to judge success while the underlying neuroimmune/immune-priming trajectory remains unchanged

What to do

  • General support strategies

    For neuroinflammatory interest areas, a central goal is to support a more balanced immune tone through the gut–brain axis. That often starts with reducing dysbiosis by improving microbial diversity and function—especially by nourishing beneficial, SCFA-producing bacteria such as butyrate producers. When the gut ecosystem is more resilient, intestinal immune signaling becomes better regulated, which may help limit excessive cytokine activity that can influence neuroimmune pathways, including glial activation and broader brain inflammatory signaling.

    Supporting gut barrier integrity is another key strategy. Diets and habits that promote healthy intestinal lining function can help reduce gut permeability and the downstream risk of inflammatory triggers crossing into immune-rich areas. Emphasizing high-fiber, plant-forward foods provides fermentable substrates that encourage SCFA generation (notably butyrate), which supports barrier strength and anti-inflammatory signaling. In contrast, low-fiber patterns, highly processed foods, and persistent stress can impair microbial metabolism and worsen barrier vulnerability, potentially intensifying systemic inflammation that may show up as brain fog, mood changes, fatigue, or sleep disruption.

    Because symptoms often reflect both GI and neurocognitive changes, lifestyle and dietary consistency matter. Regular intake of diverse, minimally processed foods, adequate protein quality, and (for those who tolerate them) fermented foods can help shape a microbiome that supports more stable immune regulation. Pairing nutrition with stress management, consistent sleep timing, and gentle activity further influences microbial composition and inflammatory signaling. Finally, recognizing individual tolerance (e.g., how specific fibers, fermented foods, or meal timing affect you) can guide practical adjustments that better support neuroinflammatory outcomes over time.

  • Lifestyle recommendations

    • Adopt a high-fiber, plant-forward diet (beans/lentils, vegetables, fruit, whole grains) to support SCFA-producing gut bacteria and improve gut barrier integrity.
    • Include a variety of prebiotic foods daily (e.g., onions, garlic, leeks, asparagus, oats, bananas when tolerated) to feed beneficial microbiota.
    • If tolerated, add fermented foods (e.g., yogurt/kefir, sauerkraut, kimchi) to increase microbial diversity—start small and increase gradually.
    • Prioritize gut-friendly meal timing and consistency (regular meal schedules; avoid large late-night meals) to reduce post-meal “crash” symptoms and support circadian alignment.
    • Reduce gut irritants that may worsen dysbiosis for some people (e.g., highly processed foods, excess alcohol, and low-fiber ultra-refined diets).
    • Support sleep and stress reduction (e.g., consistent bedtime/wake time, CBT-I or relaxation practices, mindfulness, breathing exercises) to help regulate immune tone via the gut–brain axis.
    • Maintain regular physical activity (as tolerated) to promote anti-inflammatory immune signaling and a healthier microbiome; start with walking and build gradually.

  • Nutrition recommendations

    • Increase dietary fiber to support SCFA production (aim for a variety of plants daily, including legumes, oats, chia/flax, and colorful vegetables) to strengthen gut barrier and reduce inflammatory immune tone.
    • Prioritize butyrate-supporting foods by emphasizing fermentable fibers (e.g., resistant starch and inulin-type fibers) and including foods like cooked-and-cooled potatoes, oats, beans, and whole grains.
    • Use a plant-forward diet pattern (Mediterranean-style: vegetables, olive oil, nuts, seeds, legumes, and whole grains) while minimizing ultra-processed foods and added sugars that can promote dysbiosis.
    • Consider fermented foods for microbial diversity (e.g., yogurt/kefir with live cultures, sauerkraut, kimchi, miso, tempeh) and start with small portions to assess tolerance, especially if GI symptoms are active.
    • Support intestinal integrity with an anti-inflammatory nutrient profile: ensure adequate omega-3 intake (fatty fish like salmon/sardines or algae-based DHA/EPA) and include polyphenol-rich foods (berries, cocoa, extra-virgin olive oil, green tea).
    • If symptoms include gut disruption, trial a targeted “low irritant” approach: temporarily reduce high-FODMAP trigger foods (common offenders: onions, garlic, wheat, certain fruits) and then reintroduce strategically to maintain a diverse microbiome.

  • Supplement considerations

    For neuroinflammatory interest areas, supplement choices often focus on improving gut barrier integrity, reducing immune over-activation, and supporting an anti-inflammatory microbial ecosystem. A common strategy is to enhance the production of short-chain fatty acids (SCFAs)—especially butyrate—by prioritizing fiber-based substrates (when tolerated) and/or targeted microbial support. Better SCFA availability can strengthen tight junction function, lower gut permeability, and help calm downstream immune signaling that can influence neuroimmune activity such as glial activation and brain inflammatory tone.

    Probiotic and fermented food–adjacent options may be considered for microbiome diversity and immune modulation, but the “right” approach can be individual. Some strains are selected for gut barrier and anti-inflammatory signaling (including effects on cytokine balance), while others may be more relevant for specific GI patterns like constipation or diarrhea. If symptoms include flares with certain foods or irregular bowel habits, it can be helpful to consider supplements with a clear rationale and dosing strategy, rather than assuming that higher CFU or broad blends will always be beneficial.

    Finally, it’s worth considering adjunct supplements that influence gut-immune communication and microbial metabolites. Examples often include prebiotic fibers that promote beneficial fermenters, polyphenols that can support anti-inflammatory signaling, and in some cases targeted approaches to manage endotoxin-related immune activation in susceptible contexts. Because diet quality, sleep, stress, and overall GI tolerance strongly shape outcomes, supplement use is usually most effective when paired with a fiber-forward, plant-rich dietary pattern and consistent routines that support microbial resilience—especially when neuroinflammatory symptoms co-occur with GI complaints.

  • Retesting / monitoring note

    For neuroinflammatory interest areas tied to the gut–brain axis, retesting is typically focused on confirming whether the gut microbiome and intestinal immune signaling are shifting in the direction of better barrier integrity and lower inflammatory tone. After implementing targeted dietary and lifestyle changes—such as increasing fiber and fermentable plant foods to support SCFA (especially butyrate) producers, addressing triggers that worsen GI symptoms, and improving sleep and stress consistency—retesting can help determine whether dysbiosis is improving and whether inflammatory-associated patterns are decreasing. Because microbial communities can respond gradually to interventions, a practical window is often several weeks to a few months, with the exact timing guided by how quickly symptoms and labs begin to change.

    When retesting, it’s useful to repeat the same type of stool-based microbiome and gut inflammation measures used initially so the results are comparable. For example, reassessing markers related to microbial balance, SCFA-associated taxa or metabolites, and indicators of gut barrier stress/increased immune activation can clarify whether changes are clinically meaningful, especially in people reporting a gut–symptom “cluster” (bloating, altered bowel habits) alongside cognitive or mood issues. If the initial report suggested dysbiosis with features consistent with higher immune reactivity (such as patterns linked to increased permeability or pro-inflammatory signaling), follow-up testing can help verify that the intervention reduced those signals rather than simply improving symptoms temporarily.

    If retesting suggests persistent or worsening neuroinflammation-related gut patterns, it may be appropriate to adjust the plan and then retest again after an additional targeted period, rather than making frequent changes without confirmation. In practice, many protocols follow a “test–intervene–retest” cycle, typically spanning one to three checkpoints depending on the severity of symptoms and the aggressiveness of the intervention. Consistency is key: avoid major simultaneous diet changes, new supplements, or antibiotics right before testing when possible, since these can confound interpretation. Finally, retesting should be interpreted alongside symptom tracking (GI function, sleep quality, energy, brain fog, headache/migraine changes) so the microbiome trajectory aligns with the neuroimmune outcomes you’re aiming to improve.

The importance of gut microbiome testing

  • Why testing matters

    Gut microbiome testing matters in neuroinflammatory interest areas because it can reveal whether your intestinal ecosystem is skewed toward dysbiosis—an imbalance that may promote a more inflammatory immune tone via the gut–brain axis. Since specific microbial groups help regulate gut immune communication and production of immune-modulating metabolites, test results can help identify patterns such as reduced beneficial fermenters (including butyrate producers) or overall functional gaps that may compromise barrier integrity. When the gut barrier is weakened, microbial components and inflammatory signals are more likely to interact with immune pathways, which can influence neuroimmune activity (for example, glial activation) and contribute to brain inflammation–related symptoms.

    Testing can also provide context for diet and symptom patterns that commonly overlap with neuroinflammation, such as bloating, altered bowel habits, post-meal “crashes,” headaches/migraine changes, sleep disruption, and mood or cognitive effects. By looking at microbial composition and/or inferred functional potential (e.g., fermentation capacity and metabolite-related profiles), testing may help you pinpoint which triggers or deficiencies are most plausible in your case. That insight can make interventions more targeted—supporting the right fiber sources, fermented foods, and lifestyle adjustments to encourage SCFA production and more balanced immune signaling.

    Finally, microbiome testing supports tracking and personalization over time. Because the gut ecosystem responds to food, stress, sleep, medications, and illness, a baseline test (and follow-up) can help determine whether changes are actually shifting the microbiome toward a more resilient, inflammation-calming configuration. In a neuroinflammatory context, that can be especially useful for guiding clinician-supported plans and selecting strategies most likely to improve both gut function and neuroimmune health.

  • How InnerBuddies helps

    The InnerBuddies test can help clarify whether your gut microbiome shows patterns consistent with dysbiosis that may influence neuroinflammatory pathways through the gut–brain axis. By assessing microbial composition and functional tendencies related to fermentation and immune signaling, it can reveal whether there are imbalances such as fewer beneficial, short-chain fatty acid (SCFA)–producing groups (including butyrate-associated fermenters). Because SCFAs help support intestinal barrier integrity and modulate immune tone, identifying potential functional gaps can provide clues about why some people experience a mix of gut symptoms and brain-related issues like brain fog, mood changes, fatigue, or sleep disruption.

    InnerBuddies can also provide useful context for interpreting symptom patterns that commonly overlap with neuroinflammation, such as bloating, irregular bowel habits, and “crash” feelings after meals—signals that may reflect altered gut barrier function, immune activation, or inefficient microbial processing of dietary substrates. When the gut environment is skewed toward pro-inflammatory signaling (for example, contexts that may elevate inflammatory microbial components), the immune communication between the gut and the nervous system can become more inflammatory. Testing helps you move beyond guesswork by highlighting which microbiome features may be most relevant to your gut and neuroimmune symptoms, supporting more targeted dietary and lifestyle choices.

    Finally, InnerBuddies supports personalization and tracking over time. Since the gut ecosystem can shift with diet, stress, sleep quality, medications, and recent illness, a baseline result and follow-up can show whether your interventions are steering the microbiome toward a more resilient, inflammation-balanced state. In a neuroinflammatory interest area, that longitudinal insight can be especially valuable for refining strategies that promote beneficial fermentation, barrier support, and steadier immune signaling—aimed at improving both digestive function and neuroimmune well-being.

Medical Evidence

  • Scientific evidence level

    2 (weak/emerging but inconsistent)

  • Clinical relevance note

    At present, gut microbiome measures have limited clinical relevance for neuroinflammatory interest areas. While there are reproducible broad themes in the literature (e.g., immune-metabolite pathways, altered diversity, and certain functional profiles associated with inflammatory states), the microbiome signal is not yet standardized enough for reliable diagnosis, risk stratification, or monitoring in routine practice. Reproducibility issues (batch effects, differences in 16S vs shotgun sequencing, bioinformatic pipelines, stool collection timing/handling, and analytic methods) and insufficient external validation of predictive models substantially limit clinical translation.

    From a treatment perspective, microbiome-targeted interventions remain investigational. The strongest rationale comes from mechanistic studies and animal models, and from the observation that immunologic changes can accompany microbiome shifts in some human settings. However, current human RCT evidence is generally underpowered for clinically meaningful neuroinflammatory endpoints and is confounded by concomitant medications and heterogeneous intervention types. Therefore, microbiome modulation should not be considered validated therapy or a clinical biomarker strategy for neuroinflammatory diseases outside research contexts. The most reasonable clinical stance is that the microbiome is a promising contributor/marker of neuroimmune states, but its actionable use is not yet established.

Title Journal Year Link
The gut microbiome in multiple sclerosis: evidence of inflammation and dysbiosis Nature Reviews Neurology 2017 View →
The gut microbiota regulates Alzheimer's disease-like pathology and brain inflammation via NLRP3 inflammasome Cell Reports 2016 View →
Microbiota and inflammation: potential roles in neurodegenerative diseases Cell Host & Microbe 2015 View →
Gut microbiota and neuroinflammation: microbe-mediated modulation of the brain immune system Nature Reviews Neuroscience 2015 View →
Gut microbiota dysbiosis contributes to development of neuroinflammation and experimental autoimmune encephalomyelitis Nature Immunology 2011 View →

Frequently Asked Questions

    ¿Qué es la neuroinflamación y cómo puede influir el microbioma intestinal?
    La neuroinflamación es la actividad inmunitaria en el cerebro. El microbioma puede modular señales inmunes a través del eje intestino‑cerebro, pero no es un diagnóstico; consulta a un profesional para interpretar los resultados.
    ¿Qué es el eje intestino‑cerebro?
    Es un sistema de comunicación bidireccional entre los microbios intestinales, el sistema inmune y el cerebro.
    ¿Qué son los ácidos grasos de cadena corta y por qué son importantes los productores de butirato?
    Los SCFA, como el butirato, ayudan a mantener la barrera intestinal y la señalización antiinflamatoria. Menos productores de butirato pueden debilitar la barrera.
    ¿Qué significa intestino permeable en este contexto?
    Permeabilidad intestinal aumentada, que puede permitir desencadenantes inflamatorios que afecten al sistema inmune y al cerebro.
    ¿Qué alimentos apoyan un microbioma intestinal más saludable ante la neuroinflamación?
    Alimentos ricos en fibra y patrones basados en plantas alimentan microbios beneficiosos; algunos se benefician de alimentos fermentados. La variedad es clave.
    ¿Qué es una prueba del microbioma y qué puede revelar?
    Las pruebas muestran qué microbios están presentes y sus funciones potenciales; no sustituyen un diagnóstico y deben ser interpretadas por un profesional.
    ¿Cómo puede ayudar la prueba de InnerBuddies con preocupaciones neuroinflamatorias?
    Puede identificar signos de disbiosis y brechas funcionales relacionadas con la fermentación y la señal inmunitaria para guiar la dieta y el estilo de vida.
    ¿Con qué frecuencia debo hacerme un test del microbioma?
    Una prueba de referencia y luego seguimiento para observar cambios a lo largo del tiempo; la frecuencia debe discutirse con un profesional.
    ¿Qué factores del estilo de vida influyen en el microbioma y la neuroflamación?
    El sueño, la gestión del estrés, la actividad física regular y las comidas consistentes influyen en la composición del microbioma y las respuestas inmunes.
    ¿Qué significan LPS y endotoxinas para la salud cerebral?
    Las endotoxinas pueden activar el sistema inmune en ciertos contextos; su relevancia depende del perfil inflamatorio individual.
    ¿Los probióticos o suplementos pueden ayudar con la neuroinflamación?
    Algunos pueden ayudar, pero los efectos varían. Consulta a un profesional antes de empezar.
    ¿Cuáles son los riesgos o limitaciones de las pruebas del microbioma?
    Sí. Las pruebas tienen limitaciones en precisión e interpretación; los resultados deben discutirse con un profesional.
    ¿Cómo usar los resultados para ajustar la dieta?
    Si hay menos productores de SCFA, elige fuentes de fibra que fomenten la fermentación, bajo guía profesional.
    ¿Qué síntomas pueden estar relacionados con la neuroinflamación relacionada al microbioma?
    Niebla mental, cambios de ánimo, fatiga, dolor de cabeza, interrupciones del sueño y síntomas gastrointestinales.
    ¿Cuándo debe buscarse atención médica?
    Si los síntomas persisten o empeoran, aparecen nuevos síntomas neurológicos o GI, o antes de cambios significativos en la dieta o suplementos.

    Hear from our satisfied customers!

    • "I would like to let you know how excited I am. We had been on the diet for about two months (my husband eats with us). We felt better with it, but how much better was really only noticed during the Christmas vacations when we had received a large Christmas package and didn't stick to the diet for a while. Well that did give motivation again, because what a difference in gastrointestinal symptoms but also energy in both of us!"

      - Manon, age 29 -

    • "Super help!!! I was already well on my way, but now I know for sure what I should and should not eat, drink. I have been struggling with stomach and intestines for so long, hope I can get rid of it now."

      - Petra, age 68 -

    • "I have read your comprehensive report and advice. Many thanks for that and very informative. Presented in this way, I can certainly move forward with it. Therefore no new questions for now. I will gladly take your suggestions to heart. And good luck with your important work."

      - Dirk, age 73 -